TTPH
RhumbLine Advisers’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-72,696
| Closed | -$97K | – | 3043 |
|
|
2019
Q1 | $97K | Sell |
72,696
-280
| -0.4% | -$374 | ﹤0.01% | 2863 |
|
|
2018
Q4 | $82K | Buy |
72,976
+21,089
| +41% | +$23.7K | ﹤0.01% | 2902 |
|
|
2018
Q3 | $143K | Buy |
51,887
+300
| +0.6% | +$827 | ﹤0.01% | 2811 |
|
|
2018
Q2 | $184K | Buy |
51,587
+3,625
| +8% | +$12.9K | ﹤0.01% | 2755 |
|
|
2018
Q1 | $147K | Sell |
47,962
-6,225
| -11% | -$19.1K | ﹤0.01% | 2675 |
|
|
2017
Q4 | $341K | Sell |
54,187
-3,406
| -6% | -$21.4K | ﹤0.01% | 2399 |
|
|
2017
Q3 | $394K | Buy |
57,593
+5,960
| +12% | +$40.8K | ﹤0.01% | 2437 |
|
|
2017
Q2 | $368K | Buy |
51,633
+2,780
| +6% | +$19.8K | ﹤0.01% | 2458 |
|
|
2017
Q1 | $449K | Buy |
48,853
+6,341
| +15% | +$58.3K | ﹤0.01% | 2296 |
|
|
2016
Q4 | $171K | Sell |
42,512
-14,433
| -25% | -$58.1K | ﹤0.01% | 2708 |
|
|
2016
Q3 | $218K | Sell |
56,945
-490
| -0.9% | -$1.88K | ﹤0.01% | 2632 |
|
|
2016
Q2 | $247K | Buy |
57,435
+19,180
| +50% | +$82.5K | ﹤0.01% | 2637 |
|
|
2016
Q1 | $177K | Buy |
38,255
+680
| +2% | +$3.15K | ﹤0.01% | 2771 |
|
|
2015
Q4 | $377K | Buy |
37,575
+3,660
| +11% | +$36.7K | ﹤0.01% | 2434 |
|
|
2015
Q3 | $253K | Buy |
33,915
+1,009
| +3% | +$7.53K | ﹤0.01% | 2654 |
|
|
2015
Q2 | $1.56M | Buy |
32,906
+8,050
| +32% | +$382K | 0.01% | 1582 |
|
|
2015
Q1 | $911K | Buy |
24,856
+4,775
| +24% | +$175K | ﹤0.01% | 1921 |
|
|
2014
Q4 | $797K | Buy |
20,081
+2,950
| +17% | +$117K | ﹤0.01% | 1965 |
|
|
2014
Q3 | $342K | Hold |
17,131
| – | – | ﹤0.01% | 2453 |
|
|
2014
Q2 | $231K | Buy |
17,131
+6,678
| +64% | +$90K | ﹤0.01% | 2749 |
|
|
2014
Q1 | $114K | Buy |
+10,453
| New | +$114K | ﹤0.01% | 2907 |
|
|
2013
Q3 | – | Sell |
-10,020
| Closed | -$70K | – | 2995 |
|
|
2013
Q2 | $70K | Buy |
+10,020
| New | +$70K | ﹤0.01% | 3281 |
|